{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:17:41Z","timestamp":1762939061699,"version":"3.45.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Open Respiratory Archives"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.opresp.2022.100160","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:59:09Z","timestamp":1642600749000},"page":"100160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Manejo de las enfermedades pulmonares intersticiales difusas (EPID) asociadas a enfermedades autoinmunes, por el neum\u00f3logo en las diferentes unidades de EPID en Espa\u00f1a"],"prefix":"10.1016","volume":"4","author":[{"given":"Orlando","family":"Acosta Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Aburto Barrenetxea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Bel\u00e9n","family":"Llanos Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Rodr\u00edguez Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Molina Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.opresp.2022.100160_bib0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/resp.12588","article-title":"Idiopathic interstitial pneumonias with connective tissue diseases features: A review","volume":"21","author":"Cottin","year":"2016","journal-title":"Respirology."},{"key":"10.1016\/j.opresp.2022.100160_bib0190","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3899\/jrheum.171314","article-title":"Rheumatological Assessment Is Important for Interstitial Lung Disease","volume":"45","author":"Levi","year":"2018","journal-title":"J Rheumatol."},{"key":"10.1016\/j.opresp.2022.100160_bib0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccm.2019.05.008","article-title":"Connective Tissue Disease-Associated Interstitial Lung Disease: Evaluation and Management","volume":"40","author":"Antin-Ozerkis","year":"2019","journal-title":"Clin Chest Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0034-1371530","article-title":"Cross-disciplinary collaboration in connective tissue disease- related lung disease","volume":"35","author":"Fischer","year":"2014","journal-title":"Semin Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/intqhc\/mzg031","article-title":"Good practice in the conduct and reporting of survey research","volume":"15","author":"Kelley","year":"2003","journal-title":"Int J Qual Health Care."},{"key":"10.1016\/j.opresp.2022.100160_bib0210","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1513\/AnnalsATS.201808-565CME","article-title":"Interstitial Pneumonia with Autoimmune Features","volume":"16","author":"Graney","year":"2019","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.opresp.2022.100160_bib0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1183\/09059180.00001914","article-title":"Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey","volume":"23","author":"Cottin","year":"2014","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.opresp.2022.100160_bib0220","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1164\/rccm.200402-147OC","article-title":"Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?","volume":"170","author":"Flaherty","year":"2004","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0225","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","article-title":"Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study","volume":"4","author":"Walsh","year":"2016","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fmed.2019.00246","article-title":"The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives","volume":"6","author":"Furini","year":"2019","journal-title":"Front Med (Lausanne)."},{"issue":"2","key":"10.1016\/j.opresp.2022.100160_bib0235","doi-asserted-by":"crossref","first-page":"00209","DOI":"10.1183\/23120541.00209-2018","article-title":"The characterisation of interstitial lung disease multidisciplinary team meetings: a global study","volume":"5","author":"Richeldi","year":"2019","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.opresp.2022.100160_bib0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0039-1684020","article-title":"Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease","volume":"40","author":"Wells","year":"2019","journal-title":"Semin Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/rheumatology\/keq233","article-title":"The impact of rheumatological evaluation in the management of patients with interstitial lung disease","volume":"50","author":"Castelino","year":"2011","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.opresp.2022.100160_bib0250","first-page":"801","article-title":"ILD in India: The ILD-India Registry","volume":"195","author":"Singh","year":"2017","journal-title":"AJRCCM."},{"key":"10.1016\/j.opresp.2022.100160_bib0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12890-019-0986-4","article-title":"Baseline characteristics and comorbidities in the Canadian Registry for Pulmonary Fibrosis","volume":"19","author":"Fischer","year":"2019","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0260","first-page":"64","article-title":"Report on the incidence of interstitial lung diseases in Spain","volume":"21","author":"Xaubet","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"10.1016\/j.opresp.2022.100160_bib0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2018.12.013","article-title":"Autoimmune interstitial lung disease in Latin-America. EPIMAR multicenter cohort Study","volume":"199","author":"Vivero","year":"2019","journal-title":"Clin Immunol."},{"issue":"20","key":"10.1016\/j.opresp.2022.100160_bib0270","first-page":"30004","article-title":"Connective tissue disease-associated interstitial lung disease","volume":"S2531\u20130437","author":"Oliveira","year":"2020","journal-title":"Pulmonology."},{"key":"10.1016\/j.opresp.2022.100160_bib0275","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0300-2896(03)75457-X","article-title":"Diagn\u00f3stico y tratamiento de las enfermedades pulmonares intersticiales difusas","volume":"39","author":"Xaubet","year":"2003","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2022.100160_bib0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40248-019-0179-2","article-title":"Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases","volume":"14","author":"Ciancio","year":"2019","journal-title":"Multidiscip Respir Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0285","series-title":"Pulmonary Manifestations of Systemic Diseases (ERS Monograph)","first-page":"14","article-title":"Pulmonary function tests in multisystem disorders: prejudices and pitfalls","author":"Valenzuela","year":"2019"},{"key":"10.1016\/j.opresp.2022.100160_bib0290","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/rccm.200211-1311OC","article-title":"Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis","volume":"168","author":"Collard","year":"2003","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0295","doi-asserted-by":"crossref","first-page":"1902026","DOI":"10.1183\/13993003.02026-2019","article-title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease","volume":"55","author":"Distler","year":"2020","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2022.100160_bib0300","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3899\/jrheum.141182","article-title":"Connective tissue disease-associated interstitial lung disease (CTD-ILD)-report from OMERACT CTD ILD working group","volume":"42","author":"Khanna","year":"2015","journal-title":"J Rheumatol."},{"key":"10.1016\/j.opresp.2022.100160_bib0305","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1513\/AnnalsATS.201706-423ED","article-title":"Clarity on Endpoints for Clinical Trials in Idiopathic Pulmonary Fibrosis","volume":"14","author":"Ley","year":"2017","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.opresp.2022.100160_bib0310","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40248-018-0158-z","article-title":"Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis","volume":"13","author":"Lancaster","year":"2018","journal-title":"Multidiscip Respir Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0320","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.rmed.2006.02.004","article-title":"The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis","volume":"100","author":"Lettieri","year":"2006","journal-title":"Respir Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0325","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1080\/03007995.2019.1647040","article-title":"Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management","volume":"35","author":"Wijsenbeek","year":"2019","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.opresp.2022.100160_bib0330","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Resp Rev."},{"key":"10.1016\/j.opresp.2022.100160_bib0335","doi-asserted-by":"crossref","first-page":"190109","DOI":"10.1183\/16000617.0109-2019","article-title":"Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.opresp.2022.100160_bib0340","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease; consensus recommendations, clinical uncertainties and research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0345","doi-asserted-by":"crossref","first-page":"170008","DOI":"10.1183\/16000617.0008-2017","article-title":"The role of high-resolution computed tomography in the follow-up of diffuse lung disease","volume":"26","author":"Elicker","year":"2017","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.opresp.2022.100160_bib0350","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/medicina55090580","article-title":"Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective","volume":"55","author":"Amariei","year":"2019","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/j.opresp.2022.100160_bib0355","first-page":"184","article-title":"Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease","volume":"40","author":"Wells","year":"2019","journal-title":"Crit Care Med."},{"key":"10.1016\/j.opresp.2022.100160_bib0360","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Eng J Med."}],"container-title":["Open Respiratory Archives"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663622000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663622000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:13:43Z","timestamp":1762938823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2659663622000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2659663622000066"],"URL":"https:\/\/doi.org\/10.1016\/j.opresp.2022.100160","relation":{},"ISSN":["2659-6636"],"issn-type":[{"type":"print","value":"2659-6636"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manejo de las enfermedades pulmonares intersticiales difusas (EPID) asociadas a enfermedades autoinmunes, por el neum\u00f3logo en las diferentes unidades de EPID en Espa\u00f1a","name":"articletitle","label":"Article Title"},{"value":"Open Respiratory Archives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.opresp.2022.100160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100160"}}